Early research (Phase 1)WithdrawnNCT03196401
What this trial is testing
Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma
Who this might be right for
Solitary Bone Plasmacytoma
Memorial Sloan Kettering Cancer Center